Trust Point’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$734K Buy
7,800
+688
+10% +$65.6K 0.06% 189
2026
Q2
$602K Buy
7,112
+699
+11% +$56.4K 0.05% 194
2026
Q1
$454K Buy
6,413
+1,572
+32% +$118K 0.04% 277
2025
Q4
$382K Buy
4,841
+18
+0.4% +$1.42K 0.03% 303
2025
Q3
$397K Buy
4,823
+1,612
+50% +$127K 0.03% 291
2025
Q2
$258K Sell
3,211
-496
-13% -$38.3K 0.02% 332
2025
Q1
$298K Sell
3,707
-2,813
-43% -$234K 0.03% 340
2024
Q4
$534K Buy
6,520
+28
+0.4% +$2.33K 0.04% 276
2024
Q3
$535K Buy
6,492
+54
+0.8% +$4.03K 0.04% 270
2024
Q2
$452K Sell
6,438
-775
-11% -$55.3K 0.04% 280
2024
Q1
$535K Sell
7,213
-454
-6% -$31.6K 0.04% 272
2023
Q4
$507K Buy
+7,667
New +$480K 0.04% 272

Other funds holding MET

Trust Point's MET Position: Q3 2026 in Review

Trust Point increased its MetLife (MET) stake by 9.7% in Q3 2026, buying an estimated $65.6K and bringing the position to 7,800 shares worth $734K. The position accounts for 0.06% of the portfolio, ranked #189.

Trust Point first reported a position in MET in Q4 2023 and has held it in 12 quarters since. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Trust Point held 7,800 shares of MetLife worth $734K as of Q3 2026.
  • Trust Point bought 688 MetLife shares in Q3 2026, an estimated $65.6K.
  • MetLife made up 0.06% of Trust Point's portfolio in Q3 2026, its #189 holding.
  • Trust Point first reported a position in MetLife in Q4 2023 and has held it in 12 quarters since.
  • 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.